These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35155620)

  • 81. Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome.
    Kim K; Lee TA; Touchette DR; DiDomenico RJ; Ardati AK; Walton SM
    J Manag Care Spec Pharm; 2018 Aug; 24(8):800-812. PubMed ID: 30058986
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ticagrelor improves peripheral arterial function in patients with a previous acute coronary syndrome.
    Torngren K; Ohman J; Salmi H; Larsson J; Erlinge D
    Cardiology; 2013; 124(4):252-8. PubMed ID: 23594617
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Contemporary Trends in Oral Antiplatelet Agent Use in Patients Treated with Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Kim K; Lee TA; Touchette DR; DiDomenico RJ; Ardati AK; Walton SM
    J Manag Care Spec Pharm; 2017 Jan; 23(1):57-63. PubMed ID: 28025925
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparison of prasugrel and ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized and non-randomized studies.
    Watti H; Dahal K; Zabher HG; Katikaneni P; Modi K; Abdulbaki A
    Int J Cardiol; 2017 Dec; 249():66-72. PubMed ID: 29121759
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor.
    Sun MT; Huang S; Wiviott SD; Antman EM; Roe MT; Ohman EM; Neely M; Wallentin L; Wong CX
    Am J Cardiol; 2020 Apr; 125(8):1280-1283. PubMed ID: 32081368
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Abdominal Acupuncture as an Adjunctive Therapy for the Recovery of Motor Function After Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhan J; Xiong B; Zhang P; Wang Y; Tang Y; Zhan L; Lu L
    Front Neurol; 2021; 12():705771. PubMed ID: 34650503
    [No Abstract]   [Full Text] [Related]  

  • 87. Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1-year outcomes from the GReek AntiPlatElet (GRAPE) Registry.
    Alexopoulos D; Xanthopoulou I; Deftereos S; Hamilos M; Sitafidis G; Kanakakis I; Pentara I; Vavouranakis M; Davlouros P; Hahalis G; Goudevenos J
    J Thromb Haemost; 2016 Jun; 14(6):1146-54. PubMed ID: 26990959
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model.
    Kim HK; Jeong MH; Lim KS; Kim JH; Lim HC; Kim MC; Hong YJ; Kim SS; Park KH; Chang KS
    Int J Cardiol; 2017 Aug; 240():326-331. PubMed ID: 28487152
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of Different Intensities and Durations of Aerobic Exercise on Vascular Endothelial Function in Middle-Aged and Elderly People: A Meta-analysis.
    You Q; Yu L; Li G; He H; Lv Y
    Front Physiol; 2021; 12():803102. PubMed ID: 35126182
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cardiac Shock Wave Therapy in Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Qiu Q; Chen S; Qiu Y; Mao W
    Front Cardiovasc Med; 2022; 9():932193. PubMed ID: 35958405
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Peripheral endothelial and microvascular damage in liver cirrhosis: A systematic review and meta-analysis.
    Papagiouvanni I; Theodorakopoulou MP; Sarafidis PA; Sinakos E; Goulis I
    Microcirculation; 2022 Jul; 29(4-5):e12773. PubMed ID: 35652811
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study.
    Chyrchel B; Kruszelnicka O; Surdacki A
    Cardiovasc Diabetol; 2022 Nov; 21(1):249. PubMed ID: 36397167
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease.
    Iskandar NP; Reddy AJ; Dang A; Ghauri MS; Min M; Bachir M; Bachir A; Wagh H; Tak N; Brahmbhatt H
    Cureus; 2022 Aug; 14(8):e28406. PubMed ID: 36171852
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Sahebkar A; Giua R; Pedone C; Ray KK; Vallejo-Vaz AJ; Costanzo L
    Pharmacol Res; 2016 Sep; 111():163-179. PubMed ID: 27320045
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta-analysis.
    Chen W; Zhang C; Zhao J; Xu X; Dang H; Xiao Q; Li Y; Hou H
    Clin Cardiol; 2021 Apr; 44(4):488-494. PubMed ID: 33704801
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.
    Ariotti S; Ortega-Paz L; van Leeuwen M; Brugaletta S; Leonardi S; Akkerhuis KM; Rimoldi SF; Janssens G; Gianni U; van den Berge JC; Karagiannis A; Windecker S; Valgimigli M;
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1576-1586. PubMed ID: 29805112
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis.
    Guan B; Zhao L; Ma D; Fan Y; Zhang H; Wang A; Xu H
    Front Cardiovasc Med; 2021; 8():820604. PubMed ID: 35155620
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
    Wang Z; Zhou DY; Su Y; Si LY; Xu Q
    BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.